Eloxx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update

Go back to Eloxx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
(NASDAQ: ELOX) Delayed: 17.45 -0.1 (0.57%)
Previous Close $17.55    52 Week High
Open $18.98    52 Week Low
Day High $18.98    P/E N/A 
Day Low $17.24    EPS
Volume 66,532